The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis
Xiaowen Ma, Yiming Sun, Yaqin Qi, Hiajiang Qu, Feng Zhang · 2026
Read The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis by Xiaowen Ma, Yiming Sun, Yaqin Qi, Hiajiang Qu, Feng Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13271947.txt.
Description
Xiaowen Ma and colleagues pool in 2026 studies on whether cholesterol-lowering statins change outcomes in hormone-sensitive breast cancer. Statins may reduce resistance to hormone therapy, but their effect in this cancer subtype was unsettled. The team searched five major databases for direct comparisons of users and non-users.
Seven studies covering 267,913 patients met the criteria for pooling. Statin users showed about a quarter lower risk of both cancer return and death than non-users. Repeat checks confirmed the pattern held across study choices. The authors call for large forward-looking trials to confirm the benefit and guide dosing before statins join routine cancer care.
Catalog record
| CREATOR | Xiaowen Ma, Yiming Sun, Yaqin Qi, Hiajiang Qu, Feng Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |